Gupta, V. K.; Giri, R.; Agrawal, S. Dipeptidyl Peptidase-4 Inhibitor (teneligliptin) Significantly Reduces Liver Fat Content and Delays Progression of Non-Alcoholic Steatohepatitis in Type 2 Diabetes Mellitus Patients. Int J Adv Med 2021, 8, 1817-1820.